Cumberland Pharmaceuticals (CPIX) Operating Leases (2019 - 2026)

Cumberland Pharmaceuticals (CPIX) has 8 years of Operating Leases data on file, last reported at $4.3 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 16.47% year-over-year to $4.3 million; the trailing twelve-month figure through Mar 2026 stood at $4.3 million (down 16.47% YoY), and the FY2025 full-year result was $4.9 million, changed 0.0% from the prior year.
• Operating Leases retreated to $4.3 million in Q1 2026, from $4.9 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $5.8 million in Q2 2023 to a low of $22712.0 in Q1 2022.
• A 5-year average of $4.2 million and a median of $4.9 million in 2024 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases tumbled 97.12% in 2022 and jumped 20627.01% in 2023, its largest moves.
• Tracing CPIX's Operating Leases over 5 years: stood at $4.8 million in 2022, then rose by 18.6% to $5.6 million in 2023, then declined by 12.48% to $4.9 million in 2024, then changed by 0.0% to $4.9 million in 2025, then declined by 12.06% to $4.3 million in 2026.
• Business Quant data shows CPIX's Operating Leases at $4.3 million in Q1 2026, $4.9 million in Q4 2025, and $5.0 million in Q3 2025.